Borghetti G, Von Lewinski D, Eaton DM et al (2018) Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control Front Physiol 9:414750. https://doi.org/10.3389/FPHYS.2018.01514/XML

Article  Google Scholar 

Gan Q, Wang J, Hu J et al (2020) The role of diosgenin in diabetes and diabetic complications. J Steroid Biochem Mol Biol 198:105575. https://doi.org/10.1016/J.JSBMB.2019.105575

Article  CAS  PubMed  Google Scholar 

Dutt J, Sapra A, Sheth-Dutt P et al (2020) Stevens-Johnson syndrome: a perplexing diagnosis. https://doi.org/10.7759/cureus.7374

Huynh K, Bernardo BC, McMullen JR, Ritchie RH (2014) Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther 142:375–415. https://doi.org/10.1016/J.PHARMTHERA.2014.01.003

Article  CAS  PubMed  Google Scholar 

Parveen K, Siddiqui WA, Kausar A et al (2016) Diabetic nephropathy-a major macrovascular complication. International J Pharm Res Allied Sci 5(4):132–158. Available online www.ijpras.com. Accessed 1 Jan 2016

CAS  Google Scholar 

Vella S, Petrie JR (2019) Macrovascular disease: pathogenesis and risk assessment. Medicine 47:65–71. https://doi.org/10.1016/J.MPMED.2018.11.011

Article  Google Scholar 

Lezoualc’h F, Badimon L, Baker H et al (2023) Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality. Cardiovasc Res 119:1130–1145. https://doi.org/10.1093/CVR/CVAC152

Article  PubMed  Google Scholar 

Zhao X, Liu S, Wang X et al (2022) Diabetic cardiomyopathy: clinical phenotype and practice. Front Endocrinol (Lausanne) 13:1032268. https://doi.org/10.3389/FENDO.2022.1032268/XML

Article  PubMed  Google Scholar 

Lorenzo-Almorós A, Tuñón J, Orejas M et al (2017) Diagnostic approaches for diabetic cardiomyopathy. Cardiovascular Diabetology 16:1–14. https://doi.org/10.1186/S12933-017-0506-X

Article  Google Scholar 

Evangelista I, Nuti R, Picchioni T et al (2019) Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy. Int J Mol Sci 20:3264. https://doi.org/10.3390/IJMS20133264

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian J, Zhao Y, Liu Y (2017) Roles and mechanisms of herbal medicine for diabetic cardiomyopathy: current status and perspective. Oxid Med Cell Longev 2017:8214541. https://doi.org/10.1155/2017/8214541

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia G, DeMarco VG, Sowers JR (2015) Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nature Reviews Endocrinology 2015 12:3 12:144–153. https://doi.org/10.1038/nrendo.2015.216

Swiatkiewicz I, Patel NT, Villarreal-Gonzalez MA, Taub PR (2024) Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center. BMC Med 22:1–15. https://doi.org/10.1186/S12916-024-03401-3/TABLES/3

Article  Google Scholar 

Jia G, Hill MA, Sowers JR (2018) Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res 122:624–638. https://doi.org/10.1161/CIRCRESAHA.117.311586/ASSET/9A28EDB1-1C29-484C-AB74-3C155D321551/ASSETS/IMAGES/LARGE/624FIG02.JPG

Kolb H, Martin S (2017) Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med 15:1–11. https://doi.org/10.1186/S12916-017-0901-X

Article  Google Scholar 

Lind M, Olsson M, Rosengren A et al (2012) The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes. Diabetologia 55:2946–2953. https://doi.org/10.1007/S00125-012-2681-3/TABLES/3

Article  CAS  PubMed  Google Scholar 

Edqvist J, Rawshani A, Adiels M et al (2019) Contrasting associations of body mass index and hemoglobin a1c on the excess risk of acute myocardial infarction and heart failure in type 2 diabetes mellitus. J Am Heart Assoc 8(24):e013871. https://doi.org/10.1161/JAHA.119.013871/SUPPL_FILE/JAH34666-SUP-0001-SUPINFO.PDF

Article  PubMed  PubMed Central  Google Scholar 

Wan SH, Vogel MW, Chen HH (2013) Preclinical diastolic dysfunction. J Am Coll Cardiol 63:407. https://doi.org/10.1016/J.JACC.2013.10.063

Article  PubMed  PubMed Central  Google Scholar 

Menzel A, Samouda H, Dohet F et al (2021) Common and novel markers for measuring inflammation and oxidative stress ex vivo in research and clinical practice—which to use regarding disease outcomes? Antioxidants 10:414. https://doi.org/10.3390/ANTIOX10030414

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sayin BY, Oto A (2022) Left ventricular hypertrophy: etiology-based therapeutic options. Cardiol Ther 11:203. https://doi.org/10.1007/S40119-022-00260-Y

Article  PubMed  PubMed Central  Google Scholar 

Hölscher ME, Bode C, Bugger H (2016) Diabetic cardiomyopathy: does the type of diabetes matter? Int J Mol Sci 17:2136. https://doi.org/10.3390/IJMS17122136

Article  PubMed  PubMed Central  Google Scholar 

Salvatore T, Galiero R, Caturano A et al (2022) Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options. Biomedicines 10:2274. https://doi.org/10.3390/BIOMEDICINES10092274

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mouzarou A, Hadjigeorgiou N, Melanarkiti D, Plakomyti TE (2025) The role of NT-proBNP levels in the diagnosis of hypertensive heart disease. Diagnostics 15:113. https://doi.org/10.3390/DIAGNOSTICS15010113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruiz-Franco ML, Guevara-Sánchez E, Amaya-Pascasio L et al (2023) N-terminal pro-brain natriuretic peptide levels are associated with post-stroke in-hospital complications. J Pers Med 13:474. https://doi.org/10.3390/JPM13030474

Article  PubMed  PubMed Central  Google Scholar 

Nesbitt GC, Mankad S, Oh JK (2009) Strain imaging in echocardiography: methods and clinical applications. Int J Cardiovasc Imaging 25:9–22. https://doi.org/10.1007/S10554-008-9414-1/METRICS

Article  PubMed  Google Scholar 

Mahrholdt H, Klem I, Sechtem U (2007) Cardiovascular MRI for detection of myocardial viability and ischaemia. Heart 93:122. https://doi.org/10.1136/HRT.2005.071290

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casas G, Rodríguez-Palomares JF (2022) Multimodality cardiac imaging in cardiomyopathies: from diagnosis to prognosis. J Clin Med 11:578. https://doi.org/10.3390/JCM11030578

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang K, Luo X, Liao B et al (2023) Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms. Cardiovasc Diabetol 22:1–23. https://doi.org/10.1186/S12933-023-01816-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newsholme P, Cruzat VF, Keane KN (2016) Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J 473:4527–4550. https://doi.org/10.1042/BCJ20160503C

Article  CAS  PubMed  Google Scholar 

Peng ML, Fu Y, Wu CW et al (2022) Signaling pathways related to oxidative stress in diabetic cardiomyopathy. Front Endocrinol (Lausanne) 13:907757. https://doi.org/10.3389/FENDO.2022.907757/XML

Article  PubMed  Google Scholar 

Jubaidi FF, Zainalabidin S, Taib IS et al (2021) The potential role of flavonoids in ameliorating diabetic cardiomyopathy via alleviation of cardiac oxidative stress, inflammation and apoptosis. Int J Mol Sci 22:5094. https://doi.org/10.3390/IJMS22105094

Ravarotto V, Bertoldi G, Stefanelli LF et al (2022) Pathomechanism of oxidative stress in cardiovascular-renal remodeling and therapeutic strategies. Kidney Res Clin Pract 41:533. https://doi.org/10.23876/J.KRCP.22.069

Article  PubMed  PubMed Central  Google Scholar 

Wang N, Zhang C (2024) Oxidative stress: a culprit in the progression of diabetic kidney disease. Antioxidants 13:455.